These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36476294)

  • 1. Analysis of multiple-period group randomized trials: random coefficients model or repeated measures ANOVA?
    Moyer JC; Heagerty PJ; Murray DM
    Trials; 2022 Dec; 23(1):987. PubMed ID: 36476294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mixed model for repeated measures for cluster randomized trials: a simulation study investigating bias and type I error with missing continuous data.
    Bell ML; Rabe BA
    Trials; 2020 Feb; 21(1):148. PubMed ID: 32033617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of data from group-randomized trials with repeat observations on the same groups.
    Murray DM; Hannan PJ; Wolfinger RD; Baker WL; Dwyer JH
    Stat Med; 1998 Jul; 17(14):1581-600. PubMed ID: 9699231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limitations of ordinary least squares models in analyzing repeated measures data.
    Ugrinowitsch C; Fellingham GW; Ricard MD
    Med Sci Sports Exerc; 2004 Dec; 36(12):2144-8. PubMed ID: 15570152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-normal Data in Repeated Measures ANOVA: Impact on Type I Error and Power.
    Blanca MJ; Arnau J; García-Castro FJ; Alarcón R; Bono R
    Psicothema; 2023 Feb; 35(1):21-29. PubMed ID: 36695847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some consequences of assuming simple patterns for the treatment effect over time in a linear mixed model.
    Bamia C; White IR; Kenward MG
    Stat Med; 2013 Jul; 32(15):2585-94. PubMed ID: 23242852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multilevel analysis of group-randomized trials with binary outcomes.
    Kim HY; Preisser JS; Rozier RG; Valiyaparambil JV
    Community Dent Oral Epidemiol; 2006 Aug; 34(4):241-51. PubMed ID: 16856945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generalized additive models to analyze nonlinear trends in biomedical longitudinal data using R: Beyond repeated measures ANOVA and linear mixed models.
    Mundo AI; Tipton JR; Muldoon TJ
    Stat Med; 2022 Sep; 41(21):4266-4283. PubMed ID: 35796389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical power for the two-factor repeated measures ANOVA.
    Potvin PJ; Schutz RW
    Behav Res Methods Instrum Comput; 2000 May; 32(2):347-56. PubMed ID: 10875184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated Measures ANOVA with Latent Variables to Analyze Interindividual Differences in Contrasts.
    Langenberg B; Helm JL; Mayer A
    Multivariate Behav Res; 2022; 57(1):2-19. PubMed ID: 32804595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of non-uniform correlation structure on sample size and power in multiple-period cluster randomised trials.
    Kasza J; Hemming K; Hooper R; Matthews J; Forbes AB
    Stat Methods Med Res; 2019 Mar; 28(3):703-716. PubMed ID: 29027505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and analysis of a 2-year parallel follow-up of repeated ivermectin mass drug administrations for control of malaria: Small sample considerations for cluster-randomized trials with count data.
    Jackson CL; Colborn K; Gao D; Rao S; Slater HC; Parikh S; Foy BD; Kittelson J
    Clin Trials; 2021 Oct; 18(5):582-593. PubMed ID: 34218684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variable error: variance-covariance heterogeneity, block size and type L error rates.
    Gessaroli ME; Schutz RW
    J Mot Behav; 1983 Mar; 15(1):74-95. PubMed ID: 15151885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.
    Brookes ST; Whitley E; Peters TJ; Mulheran PA; Egger M; Davey Smith G
    Health Technol Assess; 2001; 5(33):1-56. PubMed ID: 11701102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of recent methods for the analysis of small-sample cross-over studies.
    Chen X; Wei L
    Stat Med; 2003 Sep; 22(18):2821-33. PubMed ID: 12953282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appropriate statistical methods for analysing partially nested randomised controlled trials with continuous outcomes: a simulation study.
    Candlish J; Teare MD; Dimairo M; Flight L; Mandefield L; Walters SJ
    BMC Med Res Methodol; 2018 Oct; 18(1):105. PubMed ID: 30314463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of chance baseline differences in repeated measurement designs.
    Overall JE; Doyle SR
    J Biopharm Stat; 1994 Jul; 4(2):199-216. PubMed ID: 7951275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed models for data from thorough QT studies: part 2. One-step assessment of conditional QT prolongation.
    Schall R
    Pharm Stat; 2011; 10(4):293-301. PubMed ID: 21061415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.